Among patients with heart failure and reduced ejection fraction (HFrEF), those taking a "polypill" combination of three ...
Please provide your email address to receive an email when new articles are posted on . Interaction of heart disease with kidney disease may be present at subclinical stages. Echocardiographic ...
MedPage Today on MSN
Polypill for Heart Failure Boosts Cardiac Function, Treatment Adherence
N EW ORLEANS -- A polypill that combines three of the four mainstays of treatment for heart failure with reduced ejection ...
A mismatch between two common tests for kidney function may indicate a higher risk for kidney failure, heart disease, and ...
Kidney disease disproportionately affects Black communities, with Black Americans nearly four times as likely to develop ...
Long Beach Medical Center Cardiologists Pioneer Innovative Use of GLP-1 Agonists For decades, GLP-1 agonists—a class of medications including generic names like semaglutide and tirzepatide—have been ...
Following the course of lung function in treatment-naïve patients, researchers found that lung function decline does not accelerate prior to mechanical ventilation. Patterns in the decline of lung ...
Having lower physical function was associated with a higher risk of heart attack, stroke and heart failure among older adults assessed with a short physical function test. These associations between ...
Although the effects of stress and anger on ischemic heart disease and arrhythmia are well known, they are less established in heart failure, particularly those with reduced ejection fraction.
In an exclusive guest post, Lucas Daniel Cuatrecasas, JD, the author of a new trademark law study forthcoming in the New York University Law Review, outlines why failure to function has become a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results